Auxilius Pharma
United States
- Boston, Massachusetts
- 14/06/2023
- Seed
- $1,000,000
Pharma start-up with a focus on optimizing and further developing well-established medications
- Industry Pharmaceutical Manufacturing
- Website https://www.auxiliuspharma.com/
- LinkedIn https://www.linkedin.com/company/auxilius-pharma/
Related People
Jedrzej Litwiniuk, MHAFounder
United States -
Boston, Massachusetts
CEO at Auxilius Pharma, a value added generic start-up. Healthcare Strategy and Corporate Finance Consultant and Executive. M&A and Investment Professional. Co-founder and Advisory Board Member at Picket Pharmaceuticals, Inc.
Experienced executive with extensive operational and corporate finance knowledge of the healthcare industry. Since 2018 focusing on developing pharmaceutical start-up companies.
Previously I have gained my expertise as outpatient chain M&A manager, venture capital and asset management Investment Director complemented with two years experience as CEO of orthopedics and spine surgery inpatient clinic in Warsaw, Poland and co-founder and CFO of Picket Pharmaceuticals, Inc, New York based complex generic start-up company. CEMS Master diploma holder (equivalent of MBA run by top European Schools of Business). Executive Master of Health Administration at Columbia University, NY.
AfterQuery | $30,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Rork | $15,000,000 | (Apr 10, 2026)
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Elorian AI | $55,000,000 | (Apr 10, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
Golden Analytics | $7,000,000 | (Apr 9, 2026)